<DOC>
	<DOCNO>NCT02149771</DOCNO>
	<brief_summary>The purpose study determine whether TACE combine endovascular stent implantation confers survival benefit TACE alone .</brief_summary>
	<brief_title>Combination Treatment Advanced Liver Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Iodine</mesh_term>
	<criteria>( 1 ) Hepatocellular carcinoma ( HCC ) diagnosis confirm needle biopsy two coincidental image technique associate increase αfetoprotein accord American Association Study Liver Diseases ( AASLD ) guideline contrastenhancing tumour thrombus within main portal vein one firstorder branch CT MRI ; ( 2 ) ChildPugh classification grade A B； （3）Eastern Cooperative Oncology Group ( ECOG ) performance status score 2 less . advanced liver disease ( bilirubin level &gt; 3 mg/dL , ASTor ALT &gt; 5 × upper limit normal ) ； Tumor invade Inferior Vena Cava , extrahepatic spread ; contraindication doxorubicin oxaliplatin chemotherapy ; contraindication arterial procedure impair clot test ( platelet count 50 × 109/L prothrombin activity 50 % ) ; renal failure , cardiac ejection fraction &lt; 50 % ) endstage disease； patient capable cooperation procedure .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>hepatocellular carcinoma</keyword>
	<keyword>portal vein tumor thrombosis</keyword>
	<keyword>stent</keyword>
	<keyword>chemoembolization</keyword>
</DOC>